Herein, the aim of the present study is to establish the relative incidence and prognosis of aberrant c‐MET expression patterns based on mRNA and protein analysis, relative to mutational status and MET amplification, using a stage II/III population‐representative colon cancer (CC) cohort. The gene discussed is MET; the disease is malignant colon neoplasm.